Key result
Novel AGT founder mutation linked to autosomal recessive renal tubular dysgenesis, with survival following high-dose hydrocortisone.
Why the study?
Autosomal recessive renal tubular dysgenesis (ARRTD) is a rare, fatal disorder with an unknown prevalence.
Observational (n=6)
Yes
Answers are grounded in this paper and cite their sources.
A founder mutation in the AGT gene causes ARRTD in Taiwan, and high-dose hydrocortisone may be a potential rescue therapy for profound hypotension in these patients.
IntroductionAutosomal recessive renal tubular dysgenesis (ARRTD) caused by inactivation mutations in AGT, REN, ACE, and AGTR is a very rare but fatal disorder with an unknown prevalence.MethodsWe report 6 Taiwanese individuals with ARRTD from 6 unrelated families diagnosed by renal histology. Clinical features, outcome, and prevalence of carrier heterozygosity were examined.ResultsAll patients exhibited antenatal oligohydramnios, postnatal anuria, pulmonary hypoplasia, and profound hypotension refractory to interventions. Angiotensinogen (AGT) protein levels were diminished in the liver, along with reduced serum AGT, angiotensin I (Ang I) and angiotensin II (Ang II) levels. Neonatal demise occurred in all but 1 case. All individuals carried the same homozygous E3_E4 del:2870bp deletion+9bp insertion in AGT, which led to a truncated protein (1-292 amino acid). The allelic frequency of this heterozygous AGT mutation was approximately 1.2% (6/500), suggesting that ARRTD may not be exceedingly rare in Taiwan. This mutation results in skipping of exons encoding the serpin domain of AGT, which is important for renin interaction and the generation of truncated protein. In silico modeling revealed a diminished interaction between mutant AGT and renin. One patient survived after responding to high-dose hydrocortisone therapy, with resolution of profound hypotension, accompanied by an increase in serum AGT, Ang I, and Ang II levels.ConclusionThis AGT mutation may lead to the diminished interaction with renin and decreased Ang I and Ang II generation. Hydrocortisone may potentially rescue cases of ARRTD caused by this truncated AGT.
No takes yet. Share an insight, caveat, or question.
Tseng et al. (2020) conducted an observational in Autosomal Recessive Renal Tubular Dysgenesis (n=6). Hydrocortisone was evaluated. A novel homozygous founder mutation in the AGT gene was identified in 6 Taiwanese neonates with autosomal recessive renal tubular dysgenesis, with one patient surviving after high-dose hydrocortisone therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: